Survey Reveals Oncology Care Model Participants Willing to Adopt 2-Sided Risk.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 8, p. 1
- By:
- Publication type:
- Article
Works matching IS 21644403 AND DT 2020 AND VI 10 AND IP 8
Results: 25
1
2
Avelumab as Maintenance Prolongs Survival in Advanced Bladder Cancer.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 8, p. 20
- By:
- Publication type:
- Article
3
Capmatinib Shows Promise in MET-Amplified Non–Small-Cell Lung Cancer.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 8, p. 26
- By:
- Publication type:
- Article
4
FDA Approves Inqovi, a New Oral Combination Therapy, for Patients with MDS.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 8, p. 46
- Publication type:
- Article
5
Tecartus Approved for the Treatment of Patients with Relapsed or Refractory Mantle-Cell Lymphoma.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 8, p. 45
- Publication type:
- Article
6
Relugolix May Become New Standard of Care for Advanced Prostate Cancer.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 8, p. 44
- By:
- Publication type:
- Article
7
Cabozantinib plus Atezolizumab Active in Metastatic Prostate Cancer.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 8, p. 43
- By:
- Publication type:
- Article
8
Early Phase 2 Data Promising for 177Lutetium PSMA-617 in Metastatic Prostate Cancer.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 8, p. 42
- By:
- Publication type:
- Article
9
First-Line Nivolumab plus Ipilimumab Shows Activity in MSI-H and dMMR Colorectal Cancer.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 8, p. 40
- By:
- Publication type:
- Article
10
Immunotherapy Doubles Progression-Free Survival in Subset of Patients with Advanced Colorectal Cancer.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 8, p. 38
- By:
- Publication type:
- Article
11
Olaparib Maintenance Prolongs Survival by >1 Year in BRCA-Mutated Ovarian Cancer.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 8, p. 36
- By:
- Publication type:
- Article
12
Exploring the Natural History of FGFR Alterations in Patients with CCA.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 8, p. 35
- Publication type:
- Article
13
IDH1 Mutation Detection in ctDNA and Its Association with Clinical Response in Patients with Advanced iCCA in the ClarIDHy Trial.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 8, p. 35
- Publication type:
- Article
14
Combination of Ipilimumab plus Nivolumab Demonstrates Signifi cant Clinical Activity in Patients with Metastatic Biliary Tract Cancer.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 8, p. 34
- Publication type:
- Article
15
Interim Results from the FOENIX-CCA2 Trial of Futibatinib in Patients with iCCA and FGFR2 Gene Fusions.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 8, p. 34
- Publication type:
- Article
16
Retrospective Analysis of Post SecondLine Chemotherapy Outcomes in Patients with Advanced or Metastatic CCA and FGFR2 Gene Fusions.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 8, p. 34
- Publication type:
- Article
17
Cemiplimab Cost-Effective for Advanced Cutaneous Squamous-Cell Carcinoma.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 8, p. 33
- By:
- Publication type:
- Article
18
Clinical Decision Support Helps Compliance with Evidence-Based Pathways.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 8, p. 31
- By:
- Publication type:
- Article
19
Germline Analysis Proves Valuable in Selecting Targetable Treatments for Patients with Advanced Cancer.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 8, p. 30
- By:
- Publication type:
- Article
20
Adjuvant Treatment with Osimertinib is Highly Effective in EGFR-Mutated Earlier-Stage NSCLC.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 8, p. 22
- By:
- Publication type:
- Article
21
Durvalumab plus Chemotherapy Improves Overall Survival in Extensive-Stage Small-Cell Lung Cancer.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 8, p. 24
- By:
- Publication type:
- Article
22
Adjuvant Atezolizumab Does Not Show Disease-Free Survival Benefit in High-Risk Bladder Cancer.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 8, p. 21
- By:
- Publication type:
- Article
23
Few Actionable Genomic Alterations Identified in Renal-Cell Carcinoma.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 8, p. 18
- By:
- Publication type:
- Article
24
Is There a Role for Anti-Cancer Agents in the Treatment of COVID-19?
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 8, p. 1
- Publication type:
- Article
25
The Illusion of Control: Challenges and Opportunities.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 8, p. 1
- By:
- Publication type:
- Article